Learn More
Apexbio Technology LLC Clindamycin 18323-44-9 100mg

Supplier: Apexbio Technology LLC B1707100
Clindamycin (CAS 18323-44-9) is a small-molecule inhibitor targeting the bacterial 50S ribosomal subunit It is designed to disrupt peptide bond formation during protein synthesis thereby inhibiting bacterial proliferation Clindamycin exerts its biological activity primarily through binding to the 50S ribosomal subunit which interrupts peptide elongation and protein assembly In biochemical research Clindamycin demonstrates antimicrobial inhibition with reported IC50 values typically in the low micromolar range depending on bacterial strains and experimental conditions Based on these pharmacological properties Clindamycin holds research potential in microbiological and pharmacological studies for evaluating antimicrobial susceptibility bacterial ribosomal functions and mechanisms of antibiotic resistance
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.